MM

Mitra Mosharraf

Engimata, HTD Biosystems, Massachusetts Institute of Technology, Uppsala Universitet Farmaceutiska fakulteten, American Association of Pharmaceutical Scientists, Uppsala University

ORCID iD 0000-0001-8633-421X
Follow

Employment

  • American Association of Pharmaceutical Scientists Chair, Vice Chair, Nanotechnology Community
    2023 - 2026
  • Special Staffing (Exelixis) Advisor to VP of Biologics Manufacturing & CMC at Exelixis
    2021 - 2022
  • Oryn Therapeutics (United States) Vice President, Development
    2021 - 2021
  • Engimata Cofounder & Chief Executive Officer
    2019 - Present
  • HTD Biosystems Executive Vice President & Chief Scientific Officer
    2018 - Present
  • Santen Inc Director, Product Development, Biologics
    2017 - 2018
  • HTD Biosystems (United States) Chief Scientific Officer
    2005 - 2017
  • Pfizer Health AB Principal Scientist
    2003 - 2005
  • Pharmacia Sr. Scientist
    2000 - 2003

Education

  • Massachusetts Institute of Technology MBA
    2018 - 2020
  • Uppsala Universitet Farmaceutiska fakulteten PhD
    1993 - 1999
  • Uppsala University MS Pharm
    1989 - 1993

Projects & Funding

Projects & funding information is unavailable.

Publications (38)